CURE Pharmaceutical

📍 Oxnard, CA, United States🗓 Founded 2011👥 57 employees💰 Last funded May 2019
Pharmaceutical Manufacturing🌐 curepharmaceutical.com
Website LinkedIn
CURE Pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has an industry leading full-service cGMP manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (CureFilm™), the most advanced oral thin film on the market today. CURE has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel and Germany, among other markets. Our mission is to improve people's lives by redefining how medicines are delivered and experienced.
4
Total investors
1
Early stage
0
Mid stage
3
Late stage
2011
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2011–2019 · investors recorded per year
2011120193
Recent (last 2y)Earlier
Frequently asked questions
Who invested in CURE Pharmaceutical?
CURE Pharmaceutical has 4 investors on record on gritt.io, including 1 early-stage backers and 3 late-stage investors.
When did CURE Pharmaceutical last raise funding?
The most recent investment in CURE Pharmaceutical recorded on gritt.io was in May 2019.
When was CURE Pharmaceutical founded?
CURE Pharmaceutical was founded in 2011.
What industry is CURE Pharmaceutical in?
CURE Pharmaceutical operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is CURE Pharmaceutical based?
CURE Pharmaceutical is headquartered in Oxnard, CA, United States.